跳至主要内容
临床试验/CTRI/2018/02/012238
CTRI/2018/02/012238Other未知

Cost effective non invasive diagnostic modalities and predictive model for development and progression of fibrosis among patients with Hepatitis B, Hepatitis C infection or non alcoholic fatty liver disease: A hospital based retrospective followed by prospective cohort study

Institute of liver and Biliary Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
Other

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Age 18 years and above Patients who underwent liver biopsy with underlying etiology as HBV, HCV, NASH or cryptogenic or ALD (inpatient or outpatient) Metavir Fibrosis Score F0-3 for prospective study design

排除标准

  • Not willing to participate in the study Patients with chronic liver disease of other

研究者

相似试验